Human IGF2/C11orf43/GRDF ORF/cDNA clone-Lentivirus particle (NM_001127598.2)
Cat. No.: vGMLV000393
Pre-made Human IGF2/C11orf43/GRDF Lentiviral expression plasmid for IGF2 lentivirus packaging, IGF2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
IGF2/C11orf43 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLV000393 | Human IGF2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLV000393 |
| Gene Name | IGF2 |
| Accession Number | NM_001127598.2 |
| Gene ID | 3481 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 711 bp |
| Gene Alias | C11orf43,GRDF,IGF-II,PP9974 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTTTCCCCAGACCCCCAAATTATCGTGGTGGCCCCCGAGACCGAACTCGCGTCTATGCAAGTCCAACGCACTGAGGACGGGGTAACCATTATCCAGATATTTTGGGTGGGCCGCAAAGGCGAGCTACTTAGACGCACCCCGGTGAGCTCGGCCATGCAGACACCAATGGGAATCCCAATGGGGAAGTCGATGCTGGTGCTTCTCACCTTCTTGGCCTTCGCCTCGTGCTGCATTGCTGCTTACCGCCCCAGTGAGACCCTGTGCGGCGGGGAGCTGGTGGACACCCTCCAGTTCGTCTGTGGGGACCGCGGCTTCTACTTCAGCAGGCCCGCAAGCCGTGTGAGCCGTCGCAGCCGTGGCATCGTTGAGGAGTGCTGTTTCCGCAGCTGTGACCTGGCCCTCCTGGAGACGTACTGTGCTACCCCCGCCAAGTCCGAGAGGGACGTGTCGACCCCTCCGACCGTGCTTCCGGACAACTTCCCCAGATACCCCGTGGGCAAGTTCTTCCAATATGACACCTGGAAGCAGTCCACCCAGCGCCTGCGCAGGGGCCTGCCTGCCCTCCTGCGTGCCCGCCGGGGTCACGTGCTCGCCAAGGAGCTCGAGGCGTTCAGGGAGGCCAAACGTCACCGTCCCCTGATTGCTCTACCCACCCAAGACCCCGCCCACGGGGGCGCCCCCCCAGAGATGGCCAGCAATCGGAAGTGA |
| ORF Protein Sequence | MVSPDPQIIVVAPETELASMQVQRTEDGVTIIQIFWVGRKGELLRRTPVSSAMQTPMGIPMGKSMLVLLTFLAFASCCIAAYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVSRRSRGIVEECCFRSCDLALLETYCATPAKSERDVSTPPTVLPDNFPRYPVGKFFQYDTWKQSTQRLRRGLPALLRARRGHVLAKELEAFREAKRHRPLIALPTQDPAHGGAPPEMASNRK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-634 | Pre-Made Xentuzumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody |
| Biosimilar | GMP-Bios-ab-160 | Pre-Made Dusigitumab biosimilar, Whole mAb, Anti-IGF1;IGF2 Antibody: Anti-IGF/IGF-I/IGFI/MGF;C11orf43/GRDF/IGF-II/PP9974/SRS3 therapeutic antibody |
| Target Antibody | GM-Tg-g-T90572-Ab | Anti-IGF2/ C11orf43/ GRDF functional antibody |
| Target Antigen | GM-Tg-g-T90572-Ag | IGF2 protein |
| Cytokine | cks-Tg-g-GM-T90572 | insulin-like growth factor 2 (IGF2) protein & antibody |
| ORF Viral Vector | pGMLV000393 | Human IGF2 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000475 | Human IGF2 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000466 | Human IGF2 Adenovirus plasmid |
| ORF Viral Vector | vGMLV000393 | Human IGF2 Lentivirus particle |
| ORF Viral Vector | vGMLV000475 | Human IGF2 Lentivirus particle |
| ORF Viral Vector | vGMAP000466 | Human IGF2 Adenovirus particle |
Target information
| Target ID | GM-T90572 |
| Target Name | IGF2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3481 |
| Gene ID |
100034182 (Equus caballus), 101093644 (Felis catus), 16002 (Mus musculus), 24483 (Rattus norvegicus) 281240 (Bos taurus), 3481 (Homo sapiens), 483664 (Canis lupus familiaris), 710802 (Macaca mulatta) |
| Gene Symbols & Synonyms | IGF2,Igf2,IGF-II,Mpr,M6pr,Peg2,Igf-2,Igf-II,IGFII,RNIGF2,GRDF,SRS3,PP9974,C11orf43 |
| Target Alternative Names | C11orf43,GRDF,IGF-II,IGF2,IGFII,Igf-2,Igf-II,Igf2,Insulin-like growth factor 2,Insulin-like growth factor II (IGF-II),M6pr,Mpr,PP9974,Peg2,RNIGF2,SRS3,Somatomedin-A,T3M-11-derived growth factor |
| Uniprot Accession |
P01344,P01346,P07456,P09535,P51459
Additional SwissProt Accessions: P51459,P09535,P01346,P07456,P01344 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index, Cytokine Target |
| Disease | cancer, Ovary Cancer |
| Disease from KEGG | MAPK signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Hepatocellular carcinoma |
| Gene Ensembl | ENSECAG00000028346, ENSMUSG00000048583, ENSBTAG00000013066, ENSG00000167244, ENSCAFG00845011017, ENSMMUG00000047449 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


